Described herein are pharmaceutical packaging units which prevent oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive drugs, these techniques such as a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to oxygen and com